Investing.com - Ligand (NASDAQ: LGND) reported first quarter EPS of $1.20, $0.36 better than the analyst estimate of $0.84. Revenue for the quarter came in at $30.98M versus the consensus estimate of $26.69M.
Guidance
Ligand sees FY 2024 EPS of $4.25-$4.75 versus the analyst consensus of $4.44.
Ligand sees FY 2024 revenue of $130.00M-$142.00M versus the analyst consensus of $137.30M.
Ligand's stock price closed at $73.22. It is down -3.51% in the last 3 months and down -5.46% in the last 12 months.
Ligand saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Ligand's stock price’s past reactions to earnings here.
According to InvestingPro, Ligand's Financial Health score is "great performance".
Check out Ligand's recent earnings performance, and Ligand's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar